MDX 240

Drug Profile

MDX 240

Alternative Names: Anti-gp41-anti-Fc monoclonal antibody; DZ 33xM22

Latest Information Update: 23 Jun 1998

Price : $50

At a glance

  • Originator Medarex
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action HIV envelope protein gp41 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 23 Jun 1998 Discontinued-II for HIV infections treatment in Belgium (Unknown route)
  • 23 Jun 1998 Discontinued-II for HIV infections treatment in France (Unknown route)
  • 23 Jun 1998 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top